Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
176 hedge funds and large institutions have $757M invested in Spectrum Pharmaceuticals Inc in 2018 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 66 increasing their positions, 54 reducing their positions, and 32 closing their positions.
22% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 54
7% less funds holding
Funds holding: 190 → 176 (-14)
41% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 32
46% less call options, than puts
Call options by funds: $684K | Put options by funds: $1.28M
50% less capital invested
Capital invested by funds: $1.51B → $757M (-$748M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$19.1M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$14.3M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$7.6M |
| 4 |
Citigroup
New York
|
+$5.73M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.37M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$36.4M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$17.7M |
| 3 |
BlackRock
New York
|
-$16.4M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$8.4M |
| 5 |
Renaissance Technologies
New York
|
-$8.27M |
SPPI Hedge Fund Activity: Q4 2018 in Review
176 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q4 2018, worth a combined $757M — down 50% from $1.51B a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of SPPI and 19 opened new positions — a net loss of 13 holders — while 54 trimmed existing stakes and 66 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $19.1M. The largest seller was Consonance Capital Management, cutting an estimated $36.4M.
- 176 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q4 2018, down from 190 in Q3 2018.
- Funds reported $757M of Spectrum Pharmaceuticals Inc stock for Q4 2018, down 50% quarter-over-quarter.
- 19 funds opened new Spectrum Pharmaceuticals Inc positions in Q4 2018 and 32 closed out, a net change of -13 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q4 2018 was Armistice Capital, an estimated $19.1M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q4 2018 was Consonance Capital Management, an estimated $36.4M sold.
Based on aggregated 13F filings for Q4 2018.